Brief: Sanofi To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 Million

Vigil Neuroscience

22/05/2025 24:22

May 21 (Reuters) - Sanofi SA SASY.PA:

PRESS RELEASE: SANOFI TO ACQUIRE VIGIL NEUROSCIENCE, INC., ADDING A NEW INVESTIGATIONAL MEDICINE TO TREAT ALZHEIMER’S DISEASE TO THE NEUROLOGY PIPELINE

SANOFI SA - VIGIL SHAREHOLDERS TO RECEIVE $2 CVR PER SHARE

SANOFI SA - ACQUISITION WILL NOT IMPACT SANOFI'S 2025 FINANCIAL GUIDANCE

SANOFI SA - MADE $40 MILLION STRATEGIC INVESTMENT IN VIGIL

SANOFI SA - DEAL EXPECTED TO CLOSE IN Q3 2025

 SANOFI SA - TO BUY VIGIL FOR $8 PER SHARE, EQUITY VALUE $470 MILLION

Source text: ID:nGNX3x9LRY

Further company coverage: SASY.PA

 ((Reuters.Briefs@thomsonreuters.com;))